A. Wang

发表

Clinical observation on recombinant human endostatin combined with chemotherapy for advanced gastrointestinal cancer.

Haifeng Xia, Guang-Ming Wang, Shao-rong Gao, 2015, Asian Pacific journal of cancer prevention : APJCP.

Selinexor plus low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma previously treated with an immunomodulatory agent and a proteasome inhibitor (MARCH): a phase II, single-arm study

Jing Liu, Wenxi Xiang, J. Weng, 2022, BMC Medicine.

Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial

W. Novotny, W. Xu, Jie Jin, 2018, Blood.

PB1999: ATG-010 PLUS LOW-DOSE DEXAMETHASONE (SD) IN CHINESE RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PATIENTS PREVIOUSLY RECEIVED CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T)

Z. Cai, Y. Yu, J. Weng, 2021, HemaSphere.